Zydus records PAT of Rs 23 crore in Q3

2 Feb 2022 , 01:43 PM

Net sales during the quarter rose by 2.3% YoY to Rs 384.9 crore.

EBIDTA in Q3 FY22 was down 34.8% to Rs 32.3 crore from Rs 49.5 crore in Q3 FY21. EBIDTA de-grew mainly due to impact on gross margins on account of product mix and inflationary price increases in key raw materials & packing materials, the company said.

The company has taken several measures to address this challenge which shall be reflected in gross margin improvement in the coming quarters,? Zydus said.

Five of the companys brands Glucon-D, Sugar Free, Nycil, Everyuth Scrub and Everyuth Peel off face mask maintained their leadership positions in their respective categories.

The company has completed 3 years of acquisition of Heinz India. Over last 3 years, despite losing sales in critical months for two consecutive years due to COVID, the company has consolidated and grown market shares across categories, launched multiple innovations, doubled its direct distribution reach, made significant strides in growing business ahead of the category in both online and offline organized trade, reduced cost to serve and simplified the organization leading to synergy benefits much ahead of its estimates.

Zydus Wellness is engaged in the development, production, marketing and distribution of health and wellness products.

The scrip fell 1.49% to currently trade at Rs 1714.65 on the BSE.

Powered by Capital Market – Live News